The Viral Hemorrhagic Fever Consortium is a partnership of international research institutions investigating Ebola and Lassa. Our mission is to promote global health and safety by creating new products to diagnose, treat, and significantly reduce the incidence and mortality of viral hemorrhagic fevers.


Latest News & Publications

CViSB Systems Biology Workshop

We are pleased to announce that our sister consortium CViSB, is hosting the first annual CViSB Systems Biology workshop February 20-22, 2019 in La Jolla, CA. The workshop will focus on viral systems biology and the application of phylogenetic methods on the study of...

How do antibodies protect against infection with Ebola virus?

In two papers published in Cell and Cell Host Microbe VHFC investigators describe in detail antibody responses to Ebola virus. By systematic analysis of a large set of more than 170 monoclonal antibodies to Ebola virus, the researchers show which immunological...